<p>With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years. </p>

With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years.

This Startup Has A New Way To Quit Smoking. Will This Be The One That Works?

The Forbes Daily Briefing shares the best of Forbes reporting on wealth, business, entrepreneurship, leadership and more. Tune in every day, seven days a week, to hear a new story. The Daily Briefing is edited, produced and hosted by Kieran Meadows.





930398

Business

News

Tech News

The Forbes Daily Briefing shares the best of Forbes reporting on wealth, business, entrepreneurship, leadership and more. Tune in every day, seven days a week, to hear a new story. The Daily Briefing is edited, produced and hosted by Kieran Meadows. 930398

Share This Startup Has A New Way To Quit Smoking. Will This Be The One That Works?

Sign up to save your podcasts

This Startup Has A New Way To Quit Smoking. Will This Be The One That Works?

This Startup Has A New Way To Quit Smoking. Will This Be The One That Works?

More shows like Forbes Daily Briefing

Economist Podcasts

Motley Fool Money

WSJ Your Money Briefing

WSJ What’s News

World Business Report

Odd Lots

WSJ Tech News Briefing

HBR IdeaCast

WSJ Minute Briefing

Wall Street Breakfast

Steve Forbes: What's Ahead

The Journal.

The World in Brief from The Economist

Reuters World News

Bloomberg Daybreak: US Edition

Forbes Talks

Forbes Newsroom